4//SEC Filing
Miller Aine 4
Accession 0001415889-25-005351
CIK 0001583107other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 7:28 PM ET
Size
4.9 KB
Accession
0001415889-25-005351
Insider Transaction Report
Form 4
Miller Aine
SVP, DEV & HEAD OF IRE OFFICE
Transactions
- Tax Payment
Ordinary Shares
2025-02-20$9.66/sh−11,295$109,110→ 139,261 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0002012524
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 7:28 PM ET
- Size
- 4.9 KB